BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34100661)

  • 21. Adverse reactions in blood and apheresis donors: experience from two Italian transfusion centres.
    Crocco I; Franchini M; Garozzo G; Gandini AR; Gandini G; Bonomo P; Aprili G
    Blood Transfus; 2009 Jan; 7(1):35-8. PubMed ID: 19290078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of immediate adverse donation reactions on the return of volunteers undergoing platelet apheresis.
    de Farias CLG; Bassolli L; Mendrone-Junior A; de Araújo Arrais C; Duran A; Rocha V; de Almeida-Neto C
    Transfus Apher Sci; 2022 Aug; 61(4):103424. PubMed ID: 35346602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Motivational factors for blood donation in first-time donors and repeat donors: a cross-sectional study in West Pomerania.
    Suemnig A; Konerding U; Hron G; Lubenow N; Alpen U; Hoffmann W; Kohlmann T; Greinacher A
    Transfus Med; 2017 Dec; 27(6):413-420. PubMed ID: 28786224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-ignored onsite adverse donor reaction among whole blood donors: A single center experience from India.
    Rajendran V; Paonam B; Chenna D; Mohan G; Shastry S; Jose P; Kandasamy D
    Transfus Clin Biol; 2022 May; 29(2):124-128. PubMed ID: 35031508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for complications in donors at first and repeat whole blood donation: a cohort study with assessment of the impact on donor return.
    Wiersum-Osselton JC; Marijt-van der Kreek T; Brand A; Veldhuizen I; van der Bom JG; de Kort W
    Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s28-36. PubMed ID: 23867173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Machine learning-based prediction of fainting during blood donations using donor properties and weather data as features.
    Suessner S; Niklas N; Bodenhofer U; Meier J
    BMC Med Inform Decis Mak; 2022 Aug; 22(1):222. PubMed ID: 35987636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of interventions to prevent vasovagal reactions among whole blood donors: rationale and design of a large cluster randomised trial.
    McMahon A; Kaptoge S; Walker M; Mehenny S; Gilchrist PT; Sambrook J; Akhtar N; Sweeting M; Wood AM; Stirrups K; Chung R; Fahle S; Johnson E; Cullen D; Godfrey R; Duthie S; Allen L; Harvey P; Berkson M; Allen E; Watkins NA; Bradley JR; Kingston N; Miflin G; Armitage J; Roberts DJ; Danesh J; Di Angelantonio E
    Trials; 2023 Aug; 24(1):512. PubMed ID: 37563721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An intervention study for the prevention of vasovagal reactions and evaluating donors' experience: Analysis of donors' return for subsequent donation.
    Wiersum-Osselton J; Prinsze F; van den Brekel E; van Dongen A; Hermans F; Bokhorst A; der Kreek TM
    Vox Sang; 2022 Mar; 117(3):313-320. PubMed ID: 34396539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Why some canine and feline blood donors do not make the cut: A cohort study.
    Descamps M; Humm K
    Vet Rec; 2023 Jul; 193(2):e2993. PubMed ID: 37183182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of adverse events and predisposing factors in voluntary and replacement whole blood donors: A study from north India.
    Agnihotri N; Marwaha N; Sharma RR
    Asian J Transfus Sci; 2012 Jul; 6(2):155-60. PubMed ID: 22988381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Donor safety in an individualized plasmapheresis program - Results of an interim analysis.
    Taborski U; Laitinen T
    Transfus Apher Sci; 2022 Oct; 61(5):103446. PubMed ID: 35461780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of two intramuscular sedation protocols on echocardiographic variables in cats following sedation and blood donation.
    Reader RC; Yang VK; Babyak JM; Abelson AL
    J Vet Emerg Crit Care (San Antonio); 2021 Mar; 31(2):256-262. PubMed ID: 33713507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study.
    Cho JH; Rajbhandary S; van Buren NL; Fung MK; Al-Ghafry M; Fridey JL; Dy BA; Ziman A; Schreiber GB; Gammon RR; Reik R; Stubbs JR; van Buskirk CM; Kamel H; Townsend MJ; Zeller MP; Gottschall JL
    Transfusion; 2021 Sep; 61(9):2668-2676. PubMed ID: 34227689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case-controlled multicenter study of vasovagal reactions in blood donors: influence of sex, age, donation status, weight, blood pressure, and pulse.
    Trouern-Trend JJ; Cable RG; Badon SJ; Newman BH; Popovsky MA
    Transfusion; 1999 Mar; 39(3):316-20. PubMed ID: 10204597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First-time whole blood donation: A critical step for donor safety and retention on first three donations.
    Gillet P; Rapaille A; Benoît A; Ceinos M; Bertrand O; de Bouyalsky I; Govaerts B; Lambermont M
    Transfus Clin Biol; 2015; 22(5-6):312-7. PubMed ID: 26476508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of a liberal versus a restrictive pre-donation blood pressure policy on whole-blood donor adverse reactions.
    Salvadori U; Sandri M; Cemin R; Al-Khaffaf A; Daves M; Maniscalco F; Hueber R; Troi C; Griessmair A; Ploner F; Egger K; Kuehebacher G; Gentilini I; Vecchiato C
    Vox Sang; 2019 May; 114(4):317-324. PubMed ID: 30883806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency of rare, serious donor reactions: International perspective.
    Young P; Crowder L; Steele W; Irving D; Pink J; Kutner JM; Yokoyama APH; Van Buren N; O'Sullivan NW; Sayers M; Alcantara RM; van den Hurk K; Wiersum-Osselton J; Shaz B;
    Transfusion; 2021 Jun; 61(6):1780-1788. PubMed ID: 33665853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Demographical Pattern of Blood Donors and Pre-Donation Deferral Causes in Dhahran, Saudi Arabia.
    Elsafi SH
    J Blood Med; 2020; 11():243-249. PubMed ID: 32765148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-donation deferral of blood donors in a Brazilian blood bank: a 10-year experience.
    Dias PB; Lissa NM; Skare T; Fávero KB; Almeida PTR; Nisihara R
    Transfus Med; 2019 Dec; 29(6):448-453. PubMed ID: 31608541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donor tolerability of convalescent plasma donation.
    He R; Lin H; Xie S; Lv Q; Kong Y; Li L; Xu H; Wang J; Li W; Fang P; Wu Y; Liu Z
    J Clin Apher; 2021 Jun; 36(3):429-436. PubMed ID: 33587767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.